baber/WOPTO huggingface dataset:
Patent NZ-515183-A (NZ)
Title: Telecommunications data capture system
Inventor: THOMPSON ANDREW MATTHEW BURNS
IPC: H04M3/51
Filed: 2001-10-31
Abstract: A method of recording data associated with a telephone call using a remote data storage system in communication with a telephone exchange routing system comprises: i) receiving a call having associated call information to be routed; ii) transmitting at least a portion of the call information to the remote data storage system; iii) storing at least a portion of the call information using the remote data storage system; iv) retrieving call source information from the remote data storage system using at least a portion of the call information transmitted; v) assembling call routing instructions to facilitate the routing of the call received using the retrieved call source information and vi) routing the call using the telephone exchange routing system.
Patent NZ-515853-A (NZ)
Title: A method of prophylaxis and treatment by antagonising bacterial aquisition of iron, heme or porphyrin and agents useful for same
Inventor: COLLYER CHARLES ANDREW
IPC: A61K38/16
Filed: 2000-05-26
Abstract: Use of microorganisms in biological environments from where the microorganisms acquire iron, heme or porphyrin, generally but not exclusively for growth, in the manufacture of a medicament for the prophylaxis and treatment of infection is disclosed, wherein the treatment involves interrupting, reducing or otherwise antagonizing the interaction between a microbial-derived polypeptide, such as but not limited to a polypeptide having cysteine proteinase activity, and a porphyrin-containing molecule in such as heme. Particular biological environments contemplated herein include vascular regions and cavities as well as mucosal membranes in animals including mammals, reptiles, amphibians and fish and in avian species as well as hooves of livestock animals. Further disclosed are agents useful in the prophylaxis and treatment of microbial infection of biological environments such as vascular regions and cavities including mucosal membranes as well as hooves involving microbial acquisition of iron, heme or porphyrin. Such agents are particularly useful as components in therapeutic compositions. Particularly important microbial infections include infections in the oral cavity, nasopharynx, oropharynx, vagina and urethra in mammals such as humans. Other important microbial infections include infections of hooves in livestock animals such as sheep, cattle and goats.
Patent NZ-515986-A (NZ)
Title: System for determining process parameters relating to thermal processes such as, for instance, waste incineration
Inventor: VAN KESSEL LAMBERTUS BERNARDUS
IPC: F23G5/50
Filed: 2000-06-05
Abstract: The invention relates to a system for thermal combustion processes of matter such as, for instance, waste incineration. The system comprises a computer for measuring parameters of the combustion of the matter, wherein, in use, matter, such as for instance waste, is supplied to the system and combusted, thereby forming a flue gas. The system further comprises means for determining the concentration of CO2, O2 and H2O in the flue gas. The computer is arranged for determining, on the basis of the measured concentrations, the rate of combustion and/or the composition of the combustible part CHyOzof the waste supplied to the system, for the purpose of process control.
Patent NZ-523032-A (NZ)
Title: Modification of fructan biosynthesis
Inventor: SPANGENBERG GERMAN
IPC: C12N9/10
Filed: 2001-06-14
Abstract: A substantially purified or isolated nucleic acid or nucleic acid fragment encoding a fructosyl transferase homologue such as sucrose:fructan 6-fructosyltransferase (6-SFT), fructan:fructan 1-fructosyltransferase (1-FFT) or sucrose:sucrose 1-fructosyltransferase (1-SST) homologues, from a ryegrass (Lolium) species, Lolium perenne, or a functionally active fragment or variant thereof.
Patent NZ-526411-A (NZ)
Title: Tumor necrosis factor-gamma
Inventor: YU GUO-LIANG
IPC: C07K16/24
Filed: 1999-02-08
Abstract: TNF-gamma beta polynucleotides, polypeptides encoded by such polynucleotides, and the use of such polynucleotides and polypeptides are disclosed. These nucleic acid molecules and amino acid sequences are used in the treatment of cancer and Rheumatoid Arthritis. (62) Divided out of 509560
Patent NZ-527638-A (NZ)
Title: Material handling system and method for products manually processed
Inventor: JACOBSEN GLENN
IPC: B65G47/10
Filed: 2002-02-27
Abstract: The present invention provides a material handling system and method for a product to be manually processed by an operator (O) at a work-station (10). The material handling system (100) includes: batch delivery means (20) for automatically delivering batches of the product to the work-station (10) on an "as required" or "on demand" basis for manual processing by the operator; and packing container delivery means (60) for automatically delivering individual packing containers (61) to the work-station on an "as required" or "on demand" basis for filling with the product after manual processing by the operator. Each batch of product is typically supplied in a batch container (21) and the system may further include batch container dispatch means (40) for automatically dispatching the batch containers (21) from the work-station (10) on an "as required" or "on demand" basis after the operator has finished manually processing the product it contained. The system also typically includes packing container dispatch means (80) for automatically dispatching product-filled packing containers (61) from the work-station on an "as required" or "on demand" basis.
Patent NZ-527671-A (NZ)
Title: Weed killer comprising an alkyl ester of a polycarboxylic acid and a sulfonyl urea or salt thereof
Inventor: MAIER THOMAS
IPC: A01N61/00
Filed: 2002-01-19
Abstract: Disclosed are liquid weed killer formulations that contain a) one or more alkyl esters of polycarboxylic acids, and b) one or more agrochemical substances from the group of ALS inhibitors. Such formulations may also comprise surfactants, additional organic solvents, additional agrochemicals and other components, and are useful for controlling vegetation by application to the seeds , plants , parts of plants , or the general area in which the vegetation is to be controlled.
Patent NZ-529213-A (NZ)
Title: Compositions comprising neisseria meningitidis an NmC oligosaccharide, NmB outer membrane proteoliposomic vesicles and an NmB NspA protein
Inventor: GIULIANI MARZIA MONICA
IPC: A61K39/116
Filed: 2000-11-29
Abstract: Immunogenic compositions that comprising (a) NmC oligosaccharide and (b) NmB outer membrane protein proteoliposomic vesicles and (c) a NmB NspA protein, or an immunogenic fragment thereof are described for use as a medicament. (62) Divided Out of 519608
Patent NZ-530020-A (NZ)
Title: Use of a glycosaminoglycan (GAG) for the treatment of Crohn's disease and ulcerative colitis
Inventor: SPERO MICHAEL
IPC: A61K45/06
Filed: 2002-05-19
Abstract: Described is the use of a composition for the preparation of a medicament for inhibiting, reducing, or eliminating one or more symptoms of inflammatory bowel disease. The composition comprises from about 60% to about 90% iduronylglycosaminoglycan sulfate, as well as between about 10% to about 40% dermatan sulfate, or pharmaceutically acceptable salts, solvates, hydrates, or clathrates thereof. Disclosed are amounts of the composition in the medicament ranging from about 20 L.R.U to about 100,000 L.R.U.
Patent NZ-534528-A (NZ)
Title: Improved equipment for evaluating properties of trees, logs and lumber
Inventor: HAYES MICHAEL PHILIP
IPC: G01N33/46
Filed: 2004-08-04
Abstract: Equipment for evaluating the properties of trees, logs and lumber which includes an input probe; two or more matched sensing probes and a recording means associated with each probe; wherein the input probe is isolated from either or any of the sensing probes and from the recording means; and each of the sensing probes is electrically connected to the recording means.
Patent NZ-538612-A (NZ)
Title: A new process for the preparation of epothilone derivatives, new epothilone derivatives as well as new intermediate products for the process and the methods of preparing same
Inventor: KOCH GUIDO
IPC: C07D303/18
Filed: 2003-09-12
Abstract: Disclosed is a synthesis for the preparation of epothilone derivatives of formula (9) wherein R1 is methyl, and R2 has the meaning of an unsubstituted or substituted aryl, an unsubstituted or substituted heteroaryl or an unsubstituted or substituted heterocyclic radical fused to a benzene nucleus, and salts thereof, and intermediates for the synthesis of a compound of formula (9).
Patent NZ-539062-A (NZ)
Title: Fused azole-pyrimidine derivatives exhibiting enhanced potency for phosphotidylinositol-3-kinase (P13K) inhibition
Inventor: SHIMADA MITSUYUKI
IPC: C07D471/14
Filed: 2003-09-18
Abstract: The disclosure relates to fused azolepyrimidine derivatives, processes for preparing them and pharmaceutical preparations containing them. These fused azolepyrimidine derivatives exhibit enhanced potency for phosphotidylinositol-3-kinase (P13K) inhibition, especially for PI3K-gamma inhibition and can be used for the prophylaxis and treatment of diseases associated with P13K and particularly with P13K-gamma activity. More specifically, these azolepyrimidine derivatives are useful for treatment and prophylaxis of diseases as follows: inflammatory and immunoregulatory disorders, such as asthma, atopic dermatitis, rhinitis, allergic diseases, chronic obstructive pulmonary disease (COPD), septic shock, joint diseases, autoimmune pathologies such as rheumatoid arthritis, and Graves' disease, cancer, myocardial contractility disorders, heart failure, thromboembolism, ischemia, and atherosclerosis. These compounds are also useful for pulmonary hypertension, renal failure, cardiac hypertrophy, as well as neurodegenerative disorders such as Parkinson's disease, Alzheimer's disease, diabetes and focal ischemia, since the diseases also relate to P13K activity in a human or animal subject.
Patent NZ-540640-A (NZ)
Title: Methods for bonding structural elements of paper machine and industrial fabrics to one another and fabrics produced thereby
Inventor: DAVENPORT FRANCIS L
IPC: D04H3/12
Filed: 2003-11-06
Abstract: A method of manufacturing and a papermaker's or industrial fabric, which includes the application of a polymeric resin material onto preselected discrete locations on a base substrate in a controlled manner in droplets having an average diameter of 10mu (10 microns) to point bond yarns, bond spiral wound strips together or to bond layers of a fabric together.
Patent NZ-552274-A (NZ)
Title: Aequorin-containing compositions and methods of using same
Inventor: UNDERWOOD MARK Y
IPC: A61K38/00
Filed: 2005-06-21
Abstract: The use of aequorin in the manufacture of a composition for preventing or alleviating a symptom or disorder associated with calcium imbalance in a subject is disclosed, wherein the symptom or disorder associated with calcium imbalance may be related to neuronal excitability, muscle contraction, membrane permeability, cell division, hormone secretion or bone mineralization, and wherein the symptom or disorder may be caused by ischemia. In such compositions aequorin can also be provided in combination with an immune boosting agent, anti-inflammatory agent, anti-oxidant agent, anti-viral agent, or a mixture thereof.
Patent NZ-554833-A (NZ)
Title: Packaging carton made from cardboard and containing at least one aperture
Inventor: MACKENZIE THOMAS
Filed: 2007-04-30
Abstract: A packaging carton is disclosed. The packaging carton 100 comprises a main body 2 having at least one aperture 6A, 6B and an open end portion 3 which can receive and display a portion of the packaged item. The carton is characterised in that the open end portion is surrounded by a wall or walls 4A, 4B, 5A, 5B which terminate with a horizontal section of greater dimensions than the thickness of the wall(s).
Patent NZ-562048-A (NZ)
Title: Potentiator for radiation therapy comprising pyridine derivative active ingredient
Inventor: FUKUSHIMA MASAKAZU
IPC: A61P35/00
Filed: 2006-03-31
Abstract: Disclosed is the use of a pyridine derivative represented by general formula (1) wherein any two of R1, R2 and R4 represent hydroxy groups, the remaining one represents a hydrogen atom, and R3 represents a halogen atom or a cyano group, for the manufacture of a radiotherapy enhancer for enhancing the cancer therapeutic effect of radiotherapy in the treatment of lung and pancreatic cancer.
Patent NZ-565632-A (NZ)
Title: A variable rotor speed wind turbine, wind park, method of transmitting electric power and method of servicing or inspecting a variable rotor speed wind turbine
Inventor: KJAER PHILIP RICHARD JACOBSEN CARNE
Filed: 2005-07-01
Abstract: A variable rotor speed wind turbine for transmitting electric AC power to a utility grid is provided. The wind turbine includes: - an AC generator, and - a power electronic converter unit, where the wind turbine also includes a nominal output value transformer for transforming a nominal output value of the AC generator to a different nominal input value of the power electronic converter unit. Methods of operating and servicing the turbine as claimed are also provided.
Patent NZ-570715-A (NZ)
Title: Dividable galenical form allowing modified release of gliclazide as the active ingredient
Inventor: FONKNECHTEN GILLES
IPC: A61K9/20
Filed: 2008-08-22
Abstract: Disclosed is a dividable prolonged-release tablet comprising gliclazide, a cellulose derivative selected from the group consisting of hydroxymethylcellulose, hydroxyethylcellulose, hydroxypropylcellulose and/or hydroxypropyl methylcellulose and a binder selected from the group consisting of maltodextrin, polyvidone or a hydroxypropyl methylcellulose of very low viscosity, wherein the non-subdivided tablet and a portion of said tablet obtained by subdivision have similar dissolution profiles.
Patent NZ-578317-A (NZ)
Title: Ceiling panel support system
Inventor: MCDONALD PAUL
IPC: E04B9/00
Filed: 2009-07-10
Abstract: A ceiling arrangement 2 for use with an overhead ceiling structure, includes a support assembly comprising more than one support members 10 each configured so as to be suspended from the overhead ceiling structure, and a number of separating members 8 operatively associated with the support assembly. The support members 10 are arranged relative to one another so that one or more ceiling panels 6 may be releasably secured to them. The separating members 8 are arranged relative to the support assembly so as to substantially maintain relative alignment of the support assembly and the ceiling panels 6, and do not provide any support to the ceiling panels 6.
Patent NZ-578927-A (NZ)
Title: Compositions and methods for the therapy and diagnosis of ovarian cancer
Inventor: KING GORDON E
IPC: A61K48/00
Filed: 2004-05-27
Abstract: Provided is an isolated antibody, or antigen binding fragment thereof, which specifically binds to an O8E polypeptide at a specified short amino acid sequence selected from the full protein sequence. Further provided are isolated polypeptides, methods of making the antibody and vaccines comprising the isolated polypeptides. (62) Divided Out of 568111
Patent NZ-580648-A (NZ)
Title: Systems and methods for ex-vivo care of a heart using lactate as an indicator
Inventor: HASSANEIN WALEED
IPC: A61M1/10
Filed: 2008-04-24
Abstract: An organ care device for perfusing a heart and method thereof for evaluating and preserving the heart ex vivo. The device comprises a Lactate A sensor and a Lactate V sensor connected to the aorta and pulmonary vein of the heart respectively. A Lactate V-A differential is calculated using the values sensed by the sensors and is calculated at least once an hour.
Patent NZ-580984-A (NZ)
Title: Use of ivabradine as diagnostic agent in the method of coronary angiography by multislice computed tomography
Inventor: LEREBOURS-PIGEONNIERE GUY
IPC: A61K31/4184
Filed: 2009-11-05
Abstract: Disclosed is the use of ivabradine, or 3-{3-[{[(7S)-3,4-dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl]-methyl}(methyl)amino]propyl}-7,8-dimethoxy-1,3,4,5-tetrahydro-2H-3-benzazepin-2-one, of its addition salts with a pharmaceutically acceptable acid and of their hydrates, as a diagnostic agent in the method of coronary angiography by multislice (multi-cut) computed tomography.
Patent NZ-585013-A (NZ)
Title: Sheet dividers with overlayed tabs and related methods
Inventor: GREEN TARA M
IPC: B42F21/00
Filed: 2008-11-19
Abstract: 585013 A set of sheet dividers is disclosed comprising a first plurality of sheet dividers (200) and a second plurality of sheet dividers (250) each comprising a sheet with a tab extending therefrom at a different location along the same side as all other dividers in the plurality of sheet dividers. The tabs (270, 272) of the second plurality of sheet dividers extend from their respective sheets to the same or greater extent than the tabs (200, 222) of the first plurality. A tab (220, 222) of the first plurality of sheet dividers partially overlays a tab (270, 272) of the second plurality when the first (200) and second (250) plurality of sheet dividers are stacked together.
Patent NZ-589051-A (NZ)
Title: Water reservoir for a drink dispenser with integrated pump cavity formed in the bottom and a motor supported by the lid of the reservoir
Inventor: NOORDANUS MAXIMILIAAN
IPC: B67D1/10
Filed: 2009-05-05
Abstract: 589051 A water reservoir (2) with a pump is disclosed. The reservoir includes a substantially cylindrical pump cavity (16) formed in a bottom section with a rotary displacement member (12) arranged about a drive shaft (10) in the cavity (16). A motor support section (35) supports or at least partially supports the motor (11) which is connected to the displacement member (12) by the drive shaft. The motor (11) is at least partially positioned within the reservoir (2) via a hole in the lid (24).
Patent NZ-599980-A (NZ)
Title: Novel multifunctional materials for in-situ environmental remediation of chlorinated hydrocarbons
Inventor: JOHN VIJAY
IPC: C02F103/06
Filed: 2010-10-14
Abstract: NZ 599980 Disclosed is an effective in-situ injection technology for the remediation of dense nonaqueous phase liquids (DNAPLs) such as trichloroethylene (TCE) benefits from the use of decontamination agents that effectively migrate through the soil media, and react efficiently with both dissolved TCE and bulk TCE. Particularly disclosed is a remediating chlorinated hydrocarbons which are dense non aqueous phase liquids, comprising: attaching zerovalent iron nanoparticles to carbon micro spheres; and contacting the carbon supported zerovalent iron nanoparticles with a substance containing the chlorinated hydrocarbons. wherein the micro spheres have a diameter of 50 nm to 6 microns. The disclosure also relates to a decontamination system that contains highly uniform carbon microspheres preferably in the optimal size range for transport through the soil. The microspheres are preferably enveloped in a polyelectrolyte (such as carboxymethyl cellulose, CMC) to which preferably a bimetallic nanoparticle system of zerovalent iron and Pd is attached. The carbon serves as a strong adsorbent to TCE, while the bimetallic nanoparticles system provides the reactivity. The polyelectrolyte serves to stabilize the carbon microspheres in aqueous solution.; The overall system resembles a colloidal micelle with a hydrophilic shell (the polyelectrolyte coating) and a hard hydrophobic core (carbon). In contact with bulk TCE, there is a sharp partitioning of the system to the TCE side of the interface due to the hydrophobicity of the core. These multifunctional systems appear to satisfy criteria related to remediation and are relatively inexpensive and made with potentially environmentally benign materials. An aerosol process is preferably used to produce zerovalent iron particles supported on carbon. A method of lubricating includes creating carbon microspheres produced from a monosaccharide or polysaccharide, the carbon microspheres having a diameter of 50 nm to 6 microns, coating the microspheres with a surface coating and using the carbon microspheres as a lubricant.
Patent NZ-602074-A (NZ)
Title: Artificial sweeteners and performance
Inventor: STELLINGWERFF TRENT
IPC: A23L27/30
Filed: 2011-03-14
Abstract: Disclosed is nutritional composition comprising a carbohydrate fraction containing glucose and fructose as monosaccharide’s in a ratio in the range of 3:1 to 1:1, and at least one non-glycerol sugar substitute, and wherein said nutritional composition provides for one or more of the following: (i). providing an increased carbohydrate (CHO) absorption; (ii). providing an increased CHO oxidation; (iii). providing increased performance, in particular endurance performance; (iv). allowing for an enhanced blood sugar maintenance late in exercise; (v). providing an increased exogenous carbohydrate oxidation; (vi). providing faster energy delivery, in particular to working muscles; (vii). providing more sustained energy to muscles; (viii). treating or preventing symptoms of fatigue; (ix). improving cycling cadence, for example measured in revolutions per minute; and (x). decreasing ratings of perceived exertion (RPE). And in addition has reduced adverse effects upon the gastrointestinal tract Disclosed embodiments include where the sugar substitute is one of: Brazzein, Curculin, Erythritol, Glycyrrhizin, Hydrogenated starch hydrolysates, Lactitol, Lo Han Guo, Mabinlin, Maltitol, Maltooligosaccharide Mannitol, Miraculin, Monellin, Neoculin, Pentadin, Sorbitol, Stevia, Tagatose, Thaumatin, Xylitol, Acesulfame potassium, Alitame, Aspartame, salts of aspartame-acesulfame, Cyclamate, Dulcin, Glucin, Isomalt, Neohesperidin dihydrochalcone, Neotame, P-4000, Saccharin, SC45647 and/or Sucralose. The composition may further contain Vitamin C, Vitamin E, Vitamin B12, Niacin, Vitamin B6, folic acid, biotin, panthotenic acid, Vitamin B2, Vitamin B6, lleucine, L-valine and/or L-isoleucine.
Patent NZ-608519-A (NZ)
Title: Parking guide system and method
Inventor: RAFF HIMING
IPC: F21S8/00
Filed: 2013-03-20
Abstract: 608519 Disclosed is a system for guiding a driver of a vehicle into a parking space of a parking structure. The system includes an emitter (10) unit including a light source (106) and a light sensor (110). A mirror (104) is mountable to a portion of the parking structure, such that the light sensor (110) actuates said light source (106) to emit a directed beam of light (112) at said mirror (104) to illuminate a reference position to guide the driver in optimally positioning their vehicle in the parking space.
Patent NZ-616076-A (NZ)
Title: Derivatives of sulindac, use thereof and preparation thereof
Inventor: REYNOLDS ROBERT
IPC: C07D211/06
Filed: 2012-03-30
Abstract: The disclosure relates to a family of compounds that are derivatives of sulindac (abstract figure). The disclosure also relates to the method of manufacture of these compounds for treatment of cancer, chronic inflammatory disease or neurodegenerative disease and a method of preparing the compounds. Example compounds include: (Z)-2-(5-fluoro-2-methyl-1-4-(methylthio)benzylidene)-1H-inden-3-yl)-N-(2-(piperidin-1-yl)ethyl)ethanamine (Z)-N-benzyl-2-(5-fluoro-2-methyl-1-(pyridine-4-ylmethylene)-1H-inden-3-yl)ethanamine (Z)-1-(5-Fluoro-2-methyl-1-(4-(methylthlo)benzylidene)-1H-inden-3-yl)-N,N-bis(pyridin-4-ylmethy)methanamine